Ethacrynic Acid
NDC 50228-334, Ethacrynic Acid, tablet, from ScieGen Pharmaceuticals Inc.
- Product NDC
- 50228-334
- Status
- Listed
- Labeler
- ScieGen Pharmaceuticals Inc
- Dosage form
- TABLET
- Route
- ORAL
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- ANDA
- Application
- ANDA211232
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/50228-334 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- ETHACRYNIC ACID25 mg/1
Pharmacologic classes
Increased Diuresis at Loop of Henle [PE]; Loop Diuretic [EPC]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 50228-334-01 | 50228033401 | 1000 TABLET in 1 BOTTLE (50228-334-01) |
| 50228-334-10 | 50228033410 | 100 TABLET in 1 BOTTLE (50228-334-10) |
| 50228-334-30 | 50228033430 | 30 TABLET in 1 BOTTLE (50228-334-30) |
Linked data
RxNorm, label and prices
RxNorm concepts
Related lookups
FDA label sections
GET /v1/drugs/labels/d400d264-c231-4bdf-8180-eb11ab4e9f29NADAC price for package 50228033410
GET /v1/drugs/nadac/50228033410
Use it
Look up 50228-334 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/50228-334 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 50228-334. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.